COMMUNIQUÉS West-GlobeNewswire

Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/02/2018
MENLO PARK, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Editas Medicine to Participate in Upcoming Investor Conferences
08/02/2018
CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today announced that it will participate in two upcoming investor conferences. Details are as [...]
Zafgen to Present at the Leerink Partners 7th Annual Global Healthcare Conference
08/02/2018
BOSTON, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq: ZFGN ), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]
Doctor brings exercise as medicine trend to Toronto
08/02/2018
TORONTO, Feb. 08, 2018 (GLOBE NEWSWIRE) -- A Toronto doctor and his partner have launched Toronto’s first medical fitness clinic catering to boomers suffering from the chronic diseases that come with aging and a [...]
Abeona Therapeutics Reports Top-Line Data from Phase 1/2 Gene Therapy Trial in MPS IIIA
08/02/2018
ABO-102 results presented at WORLDSymposium for Lysosomal Diseases show significant time- and dose-dependent reduction of underlying disease pathology, including decreased CSF and urine GAGs (HS fragments) and [...]
ProCare Pain Solutions Welcomes New President
08/02/2018
MELVILLE, N.Y., Feb. 08, 2018 (GLOBE NEWSWIRE) -- ProCare Pain Solutions , a division of North American Partners in Anesthesia (NAPA), is pleased to announce that Michael Lemonds has joined ProCare as president. Mr. [...]
IBA SA : IBA - TRANSPARENCY NOTIFICATION
08/02/2018
IBA - TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, February 08, 2018, 17.35 - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that [...]
IBA SA : IBA - NOTIFICATION DE TRANSPARENCE
08/02/2018
IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 08 février 2018, 17.35 - IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]
Elite Pharmaceuticals and SunGen Pharma File ANDA
08/02/2018
NORTHVALE, N.J., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP ) a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2018
08/02/2018
Communiqué de presse Villepinte, le 8 février 2018 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]
iCAD Named a Top Artificial Intelligence Medical Imaging Solution Provider by Healthcare Tech Outlook
08/02/2018
PowerLook ® Tomo Detection Cited for Innovations in Early Breast Cancer Detection and Supporting Efficient Radiology Workflow NASHUA, N.H., Feb. 08, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD ), a global leader [...]
Immunocore Announces Leadership Change
08/02/2018
PRESS RELEASE Immunocore Announces Leadership Change Oxford, UK and Philadelphia, USA, 8 February 2018 Immunocore Limited, the soluble TCR company developing first-in-class biologics that have the potential to transform [...]
Tyme Announces Interim Phase II Safety and Efficacy Data for SM-88 in Prostate Cancer at 2018 ASCO Genitourinary Cancers Symposium
08/02/2018
92% of Patients Have Maintained Radiographic Progression-Free Survival at a Median of 12 Months Since Biochemical-Recurrence All Patients Have Reported Stable Cognitive and Sexual Function on SM-88 Treatment No Reported [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
08/02/2018
FIT Biotech Oy Company release February 8, 2018 at 04:00 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes approved by the Board on December [...]
Adamas Announces Publication of Amantadine Immediate Release Subgroup Analysis From EASE LID 2 Open-label Study in Movement Disorders Clinical Practice
08/02/2018
EMERYVILLE, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that subgroup analyses of Parkinson’s disease patients taking amantadine immediate release (IR) who were [...]
Syneos Health Names Lisa van Capelle Chief Human Resources Officer
08/02/2018
RALEIGH, N.C., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq: SYNH ), the only fully integrated biopharmaceutical solutions organization, has announced the appointment of Lisa van Capelle as Chief Human [...]
Denali Therapeutics and Lonza Pharma & Biotech Announce Exclusive Partnership to Develop and Produce Biologic Medicines
08/02/2018
Partnership aims to develop drugs for neurodegenerative diseases Denali will draw on Lonza’s expertise in developing and manufacturing complex biologic molecules BASEL, Switzerland and SOUTH SAN FRANCISCO, Calif., Feb. [...]
Gemphire Announces Pricing of $22 Million Public Offering of Common Stock
08/02/2018
LIVONIA, Mich., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders [...]
Novo Nordisk files annual report with the SEC
08/02/2018
Bagsværd, Denmark, 8 February 2018 - Novo Nordisk A/S has filed its Annual Report 2017 on Form 20-F for the financial year 2017 with the US Securities and Exchange Commission (SEC), incorporating by reference parts of [...]

Pages